RASSF1 promoter methylation has been seen in CML-derived erythroleukaemia K562 cell line but the results could not be replicated in CML patients at different clinical stages [36]. This evidence concerns the gene RASSF1 and chronic myelogenous leukemia, BCR-ABL1 positive.